Skip to Main content Skip to Navigation
Journal articles

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group

Arjan Loosdrecht 1 Wolfgang Kern 2 Anna Porwit 3 Peter Valent 4 Sharham Kordasti 5 Eline Cremers 6 Canan Alhan 1 Carolien Duetz 1 Alan Dunlop 7 Willemijn Hobo 8 Frank Preijers 8 Orianne Wagner‐ballon 9, 10 Nicolas Chapuis 11, 12 Michaela Fontenay 11, 12 Peter Bettelheim 13 Lisa Eidenschink‐brodersen 14 Patricia Font 15 Ulrika Johansson 16 Michael Loken 14 Jeroen Marvelde 17 Sergio Matarraz 18 Kiyoyuki Ogata 19 Uta Oelschlaegel 20 Alberto Orfao 18 Katherina Psarra 21 Dolores Subirá 22 Denise Wells 14 Marie Béné 23, 24 Matteo Della Porta 25, 26 Kate Burbury 27 Frauke Bellos 2 Vincent Velden 17 Theresia Westers 1 Leonie Saft 28 Robin Ireland 29 
Abstract : This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and suspected myelodysplastic syndromes (MDS) by the European LeukemiaNet international MDS Flow Working Group (ELN iMDS Flow WG). The WHO 2016 classification recognizes that FCM contributes to the diagnosis of MDS and may be useful for prognostication, prediction, and evaluation of response to therapy and follow-up of MDS patients.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03540442
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, January 24, 2022 - 8:59:58 AM
Last modification on : Wednesday, April 27, 2022 - 4:25:19 AM
Long-term archiving on: : Monday, April 25, 2022 - 6:19:40 PM

File

Cytometry Part B Clinical - 20...
Publication funded by an institution

Identifiers

Citation

Arjan Loosdrecht, Wolfgang Kern, Anna Porwit, Peter Valent, Sharham Kordasti, et al.. Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group. Cytometry Part B: Clinical Cytometry, Wiley, 2021, Online ahead of print. ⟨10.1002/cyto.b.22044⟩. ⟨inserm-03540442⟩

Share

Metrics

Record views

14

Files downloads

32